VVOS
Vivos Therapeutics, Inc.
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Operating | |||||||
| Operating Cash Flow | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — |
| Investing | |||||||
| Capital Expenditures | 2.3M | 568,000 | 803,000 | 924,000 | 2.4M | 120,000 | 175,599 |
| Acquisitions | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — |
| Financing | |||||||
| Debt Repayment | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — |
| Summary | |||||||
| Free Cash Flow | -17.6M | -13.3M | -12.7M | -20.5M | -18.1M | -5.8M | -5.5M |
| Net Change in Cash | — | — | — | — | — | — | — |